Patents by Inventor Lyle D. Crossland

Lyle D. Crossland has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7202085
    Abstract: DNA constructs and other compositions and methods for controlling gene expression in eukaryotic cells and organisms are derived from bacterial quorum sensing systems. One or more cis elements from the luxI promoter (“lux box”) or a functionally similar sequence are incorporated in a eukaryotic promoter. A receptor protein from the LuxR family of transcriptional regulators, upon binding an acylated homoserine lactone (AHL) compound, interacts with the lux box, modulating the activity of the promoter.
    Type: Grant
    Filed: June 3, 2005
    Date of Patent: April 10, 2007
    Assignee: Calgene LLC
    Inventors: Tim N. Oulmassov, Kevin E. McBride, Paula C. Miller, John C. Anderson, Lyle D. Crossland, Thomas H. Adams, Barbara A. Qurollo, Victoria Gavrias
  • Patent number: 6943243
    Abstract: DNA constructs and other compositions and methods for controlling gene expression in eukaryotic cells and organisms are derived from bacterial quorum sensing systems. One or more cis elements from the luxI promoter (“lux box”) or a functionally similar sequence are incorporated in a eukaryotic promoter. A receptor protein from the LuxR family of transcriptional regulators, upon binding an acylated homoserine lactone (AHL) compound, interacts with the lux box, modulating the activity of the promoter.
    Type: Grant
    Filed: February 6, 2003
    Date of Patent: September 13, 2005
    Assignee: Calgene LLC
    Inventors: Tim N. Oulmassov, Kevin E. McBride, Paula C. Miller, John C. Anderson, Lyle D. Crossland, Thomas H. Adams, Barbara A. Qurollo, Victoria Gavrias
  • Patent number: 6939711
    Abstract: The present invention is drawn to a method of controlling gene expression in plants. Specifically, the method comprises obtaining a transgenic plant comprising at least two receptor expression cassettes and at least one target expression cassette. The first receptor expression cassette comprises a nucleotide sequence for a 5? regulatory region operably linked to a nucleotide sequence which encodes a first receptor polypeptide, and a 3? termination region. The second receptor expression cassette comprises a nucleotide sequence for a 5? regulatory region operably linked to a nucleotide sequence which encodes a second receptor polypeptide, and a 3? termination region.
    Type: Grant
    Filed: March 21, 2001
    Date of Patent: September 6, 2005
    Assignee: Syngenta Investment Corporation
    Inventors: Stephen A. Goff, Lyle D. Crossland, Laura S. Privalle
  • Publication number: 20030237117
    Abstract: Methods for transformation of maize with nucleic acid sequences of interest are disclosed. The method involves subjecting immature zygotic embryos or Type I callus to high velocity microprojectile bombardment. The method is capable of producing transformed maize lines of commercial importance and their hybrid combinations.
    Type: Application
    Filed: April 30, 2002
    Publication date: December 25, 2003
    Inventors: Michael Koziel, Nalini Desai, Kelly Lewis, Vance Kramer, Gregory Warren, Steve Evola, Lyle D. Crossland, Martha Wright, Ellis Merlin, Karen Launis, Steven J. Rothstein, Cindy Bowman, John L. Dawson, Erik Dunder, Gary M. Pace, Jan Suttie, Nadine Carozzi, Annick De Framond, James O. Linder, Robert L. Miller, Bruce W. Skillings, Alan W. Mousel, Albert R. Hornbrook, Christopher P. Clucas, Moez R. Meghji, Andreas H. Tanner, Francis E. Cassagne, Gilles Pollini, Terry Ray Colbert, Francis P. Cammack
  • Publication number: 20030224483
    Abstract: DNA constructs and other compositions and methods for controlling gene expression in eukaryotic cells and organisms are derived from bacterial quorum sensing systems. One or more cis elements from the luxI promoter (“lux box”) or a functionally similar sequence are incorporated in a eukaryotic promoter. A receptor protein from the LuxR family of transcriptional regulators, upon binding an acylated homoserine lactone (AHL) compound, interacts with the lux box, modulating the activity of the promoter.
    Type: Application
    Filed: February 6, 2003
    Publication date: December 4, 2003
    Inventors: Tim N. Oulmassov, Kevin E. McBride, Paula C. Miller, John C. Anderson, Lyle D. Crossland, Thomas H. Adams, Barbara A. Qurollo, Victoria Gavrias
  • Patent number: 6518066
    Abstract: DNA constructs and other compositions and methods for controlling gene expression in eukaryotic cells and organisms are derived from bacterial quorum sensing systems. One or more cis elements from the luxI promoter (“lux box”) or a functionally similar sequence are incorporated in a eukaryotic promoter. A receptor protein from the LuxR family of transcriptional regulators, upon binding an acylated homoserine lactone (AHL) compound, interacts with the lux box, modulating the activity of the promoter.
    Type: Grant
    Filed: June 30, 2000
    Date of Patent: February 11, 2003
    Assignee: Calgene LLC
    Inventors: Tim N. Oulmassov, Kevin E. McBride, Paula C. Miller, John C. Anderson, Lyle D. Crossland, Thomas H. Adams, Barbara A. Qurollo, Victoria Gavrias
  • Patent number: 6403865
    Abstract: Methods for transformation of maize with nucleic acid sequences of interest are disclosed. The method involves subjecting immature zygotic embryos or Type I callus to high velocity microprojectile bombardment. The method is capable of producing transformed maize lines of commercial importance and their hybrid combinations.
    Type: Grant
    Filed: May 10, 1995
    Date of Patent: June 11, 2002
    Assignee: Syngenta Investment Corp.
    Inventors: Michael G. Koziel, Nalini M. Desai, Kelly S. Lewis, Vance C. Kramer, Gregory W. Warren, Stephen V. Evola, Lyle D. Crossland, Martha S. Wright, Ellis J. Merlin, Karen L. Launis, Steven J. Rothstein, Cindy G. Bowman, John L. Dawson, Erik M. Dunder, Gary M. Pace, Janet L. Suttie, Nadine Carozzi, Annick De Framond, James O. Linder, Robert L. Miller, Bruce W. Skillings, Alan W. Mousel, Albert R. Hornbrook, Christopher P. Clucas, Moez Rajabali Meghji, Andreas H. Tanner, Francis E. Cassagne, Gilles Pollini, Terry Ray Colbert, Francis P. Cammack
  • Publication number: 20010022004
    Abstract: The present invention is drawn to a method of controlling gene expression in plants. Specifically, the method comprises obtaining a transgenic plant comprising at least two receptor expression cassettes and at least one target expression cassette. The first receptor expression cassette comprises a nucleotide sequence for a 5′ regulatory region operably linked to a nucleotide sequence which encodes a first receptor polypeptide, and a 3′ termination region. The second receptor expression cassette comprises a nucleotide sequence for a 5′ regulatory region operably linked to a nucleotide sequence which encodes a second receptor polypeptide, and a 3′ termination region.
    Type: Application
    Filed: March 21, 2001
    Publication date: September 13, 2001
    Inventors: Stephen A. Goff, Lyle D. Crossland, Laura S. Privalle
  • Patent number: 6147282
    Abstract: The present invention is drawn to a method of controlling gene expression in plants. Specifically, the method comprises obtaining a transgenic plant comprising at least two receptor expression cassettes and at least one target expression cassette. The first receptor expression cassette comprises a nucleotide sequence for a 5' regulatory region operably linked to a nucleotide sequence which encodes a first receptor polypeptide, and a 3' termination region. The second receptor expression cassette comprises a nucleotide sequence for a 5' regulatory region operably linked to a nucleotide sequence which encodes a second receptor polypeptide, and a 3' termination region.
    Type: Grant
    Filed: January 20, 1999
    Date of Patent: November 14, 2000
    Assignee: Novartis Finance Corporation
    Inventors: Stephen A. Goff, Lyle D. Crossland, Laura S. Privalle
  • Patent number: 5880333
    Abstract: The present invention is drawn to a method of controlling gene expression in plants. Specifically, the method comprises obtaining a transgenic plant comprising at least two receptor expression cassettes and at least one target expression cassette. The first receptor expression cassette comprises a nucleotide sequence for a 5' regulatory region operably linked to a nucleotide sequence which encodes a first receptor polypeptide, and a 3' termination region. The second receptor expression cassette comprises a nucleotide sequence for a 5' regulatory region operably linked to a nucleotide sequence which encodes a second receptor polypeptide, and a 3' termination region.
    Type: Grant
    Filed: January 21, 1998
    Date of Patent: March 9, 1999
    Assignee: Novartis Finance Corporation
    Inventors: Stephen A. Goff, Lyle D. Crossland, Laura S. Privalle
  • Patent number: 5859336
    Abstract: DNA sequences optimized for expression in plants are disclosed. The DNA sequences preferably encode for an insecticidal polypeptides, particularly insecticidal proteins from Bacillus thuringiensis. Plant promoters, particular tissue-specific and tissue-preferred promoters are also provided. Additionally disclosed are transformation vectors comprising said DNA sequences. The transformation vectors demonstrate high levels of insecticidal activity when transformed into maize.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: January 12, 1999
    Assignee: Novartis Corporation
    Inventors: Michael G. Koziel, Nalini M. Desai, Kelly S. Lewis, Gregory W. Warren, Stephen V. Evola, Lyle D. Crossland, Martha S. Wright, Ellis J. Merlin, Karen L. Launis, Cindy G. Bowman, John L. Dawson, Erik M. Dunder, Gary M. Pace, Janet L. Suttie
  • Patent number: 5824542
    Abstract: The present invention provides a dual method for producing male-sterile plants. Two genetically transformed plants, parents 1 and 2 are crossed to obtain male-sterile offspring. Parent 1 is transformed with an expression cassette comprising a nucleotide sequence encoding an anther-specific promoter which is operably linked to a nucleotide sequence encoding a transactivator. Parent 2 is transformed with an expression cassette comprising a target nucleotide sequence, which is capable of being activated by the transactivator, operably linked to a nucleotide sequence which encodes RNA or a polypeptide which will disrupt the formation of viable pollen. Therefore, crossing parent 1 with parent 2 results in male-sterile offspring. The male-sterile plants are useful for producing hybrid seed.The invention also provides compositions and methods for high level expression of a coding region of interest in a plant.
    Type: Grant
    Filed: May 23, 1995
    Date of Patent: October 20, 1998
    Assignee: Novartis Finance Corporation
    Inventors: Lyle D. Crossland, Annmarie Tuttle, Jeffrey I. Stein
  • Patent number: 5659124
    Abstract: The present invention provides a dual method for producing male-sterile plants. Two genetically transformed plants, parents 1 and 2 are crossed to obtain male-sterile offspring. Parent 1 is transformed with an expression cassette comprising a nucleotide sequence encoding an anther-specific promoter which is operably linked to a nucleotide sequence encoding a transactivator. Parent 2 is transformed with an expression cassette comprising a target nucleotide sequence, which is capable of being activated by the transactivator, operably linked to a nucleotide sequence which encodes RNA or a polypeptide which will disrupt the formation of viable pollen. Therefore, crossing parent 1 with parent 2 results in male-sterile offspring. The male-sterile plants are useful for producing hybrid seed.The invention also provides compositions and methods for high level expression of a coding region of interest in a plant.
    Type: Grant
    Filed: January 3, 1995
    Date of Patent: August 19, 1997
    Assignee: Novartis Corporation
    Inventors: Lyle D. Crossland, Annmarie Tuttle, Jeffrey I. Stein
  • Patent number: 5625136
    Abstract: DNA sequences optimized for expression in plants are disclosed. The DNA sequences preferably encode for an insecticidal polypeptides, particularly insecticidal proteins from Bacillus thuringiensis. Plant promoters, particular tissue-specific and tissue-preferred promoters are also provided. Additionally disclosed are transformation vectors comprising said DNA sequences. The transformation vectors demonstrate high levels of insecticidal activity when transformed into maize.
    Type: Grant
    Filed: September 25, 1992
    Date of Patent: April 29, 1997
    Assignee: Ciba-Geigy Corporation
    Inventors: Michael G. Koziel, Nalini M. Desai, Kelly S. Lewis, Vance C. Kramer, Gregory W. Warren, Stephen V. Evola, Lyle D. Crossland, Martha S. Wright, Ellis J. Merlin, Karen L. Launis, Steven J. Rothstein, Cindy G. Bowman, John L. Dawson, Erik M. Dunder, Gary M. Pace, Janet L. Suttie
  • Patent number: 5477002
    Abstract: cDNA sequences are disclosed which are expressed specifically in the anther of a plant. Genomic DNA sequences corresponding to the cDNA clones are obtained using the cDNA clones as hybridization probes. Recombinant, or chimeric, DNA sequences are constructed in which the promoter sequence from anther-specific genomic clones are operatively linked to a DNA sequence coding for a desired polypeptide. Transgenic plants are made in which the chimeric DNA sequences are expressed in the anther of the transgenic plant. In a preferred embodiment, the coding DNA sequence expresses a polypeptide which will disrupt formation of viable pollen, resulting in a male-sterile plant.
    Type: Grant
    Filed: March 7, 1994
    Date of Patent: December 19, 1995
    Assignee: Ciba-Geigy Corporation
    Inventors: Annmarie B. Tuttle, Lyle D. Crossland
  • Patent number: 5409823
    Abstract: The present invention provides a dual method for producing male-sterile plants. Two genetically transformed plants, parents 1 and 2 are crossed to obtain male-sterile offspring. Parent 1 is transformed with an expression cassette comprising a nucleotide sequence encoding an anther-specific promoter which is operably linked to a nucleotide sequence encoding a transactivator. Parent 2 is transformed with an expression cassette comprising a target nucleotide sequence, which is capable of being activated by the transactivator, operably linked to a nucleotide sequence which encodes RNA or a polypeptide which will disrupt the formation of viable pollen. Therefore, crossing parent 1 with parent 2 results in male-sterile offspring. The male-sterile plants are useful for producing hybrid seed.The invention also provides compositions and methods for high level expression of a coding region of interest in a plant.
    Type: Grant
    Filed: September 24, 1992
    Date of Patent: April 25, 1995
    Assignee: Ciba-Geigy Corporation
    Inventors: Lyle D. Crossland, Annmarie Tuttle, Jeffrey I. Stein